Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Analysts expect Sun to continue to be more aggressive in chasing speciality assets, but a successful launch is necessary for ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Shareholder law firm Julie & Holleman LLP is investigating the proposed $4.10 per share sale of Checkpoint Therapeutics ...

Sun Pharma surges 3% on Checkpoint Therapeutics acquisition; Motilal Oswal maintains 'Buy' with 22% upside potential. Read ...

Sun Pharma share price today reached ₹1,651.80, a 2.50% rise from its last close of ₹1,611.50. The rise is despite the ...

Sun Pharmaceutical Industries Ltd has entered into an agreement to acquire US-based immunotherapy and targeted oncology ...

This came to pass after a landmark acquisition of US-based biotech company Checkpoint Therapeutics. Sun Pharma acquired the Massachusetts-based company for a staggering USD 355 million or about Rs ...

ICICI Securities is bullish on Sun Pharmaceutical Industries recommended buy rating on the stock with a target price of Rs 1895 in its research report dated March 11, 2025.

Vikas Khot Sun Pharma to acquire cancer drug maker Checkpoint for $355 million. Sun Pharmaceutical Industries has agre ...

Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This ...